Merck Sante

USPTO Granted Patents = 5

EPO Patents = 2

Trademarks = 2

Forward Citations = 17

Loading Chart...

18 inventors (with patents filed for the assignee):

Gérard Moinet (2 out of 26 patents)

Micheline R Kergoat (2 out of 25 patents)

Didier Mesangeau (2 out of 13 patents)

4. Daniel Cravo (2 out of 26 patents)

5. Liliane Doare (2 out of 12 patents)

6. Marc Lecomte (1 out of 3 patents)

7. Ulriche Denis (1 out of 1 patent)

8. Clarisse Paget (1 out of 1 patent)

9. Nicolas Wiernsperger (1 out of 2 patents)

10. Yves Bonhomme (1 out of 15 patents)

11. Sophie Tartare-Deckert (1 out of 1 patent)

12. Emmanuel Van Obberghen (1 out of 1 patent)

13. Geoffrey Nicholson (1 out of 2 patents)

14. Michel Lagarde (1 out of 3 patents)

15. Gillian Cave (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 8119609 - Methods of treating diabetic retinopathy with pericyte apoptosis inhibitors (2012-02-21),

2. 7767676 - Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses (2010-08-03),

3. 7651844 - Method for screening agents capable of treating obesity (2010-01-26),

4. 7452883 - Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses (2008-11-18),

5. RE38629 - Solid oral dosage form comprising a combination of metformin and glibenclamide (2004-10-19),

Merck Sante is a leading pharmaceutical company committed to improving the health and well-being of people around the world. With a focus on research and innovation, Merck Sante develops and markets a wide range of healthcare products and services, including prescription medicines, vaccines, and over-the-counter remedies. Through partnerships with healthcare professionals and organizations, Merck Sante strives to address the diverse needs of patients and promote a healthier future for all.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

5 Patents

#220 in

#2,810 in France

FR